講演情報
[IO2-5]Pregnancy outcomes after first-trimester exposure to orexin receptor antagonists and ramelteon: Findings based on data from the teratology information institutes in Japan.
Yoriko Miura1,3, Naho Yakuwa2, Mikako Goto2, Miki Akabane1, Masayuki Ishikawa3,4, Masashi Uchida3,4, Shingo Yamazaki3,4, Itsuko Ishii3,4, Koushi Yamaguchi2 (1.Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan., 2.Japan Drug Information Institute in Pregnancy, Integrated Center for Women's Health, National Center for Child Health and Development, Tokyo, Japan., 3.Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan., 4.Division of Pharmacy, Chiba University Hospital, Chiba, Japan.)
閲覧にはパスワードが必要です
コメント
コメントの閲覧・投稿にはログインが必要です。ログイン
